Why Catalent?

Catalent’s broad and industry-leading cell therapy expertise enables access to comprehensive solutions to get your life-saving cell therapies to the clinic faster and commercialize them more efficiently. With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service CDMO partner for cell therapy.

Our unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including chimeric antigen receptor T cells (CAR-T), T cell receptors (TCR), tumor-infiltrating leukocytes (TILs), natural killer cells (NKs), iPSCs, and MSCs. Catalent enables fully integrated cell therapy services, from iPSC differentiation, development, and manufacturing expertise, to process and analytical development across cell types, to clinical and commercial manufacturing in the United States and Europe.